Mochida Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 1, 2023 and Provides Dividend Guidance for the Year Ending March 31, 2024
November 02, 2023 at 01:00 am EDT
Share
Mochida Pharmaceutical Co., Ltd. announced dividend for the second quarter ended September 30, 2023 and provided dividend guidance for the year ending March 31, 2024. for the second quarter end, the company declared dividend of JPY 40.00 per share as same as a year ago. Payable on December 1, 2023.
For the year end, the company expects dividend of JPY 40.00 per share as same as a year ago.
Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
Mochida Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 1, 2023 and Provides Dividend Guidance for the Year Ending March 31, 2024
MOCHIDA PHARMACEUTICAL CO., LTD. 
